Skip to main content
Article thumbnail
Location of Repository

Phenotyping and Genotyping of Idiopathic Infantile Nystagmus

By Shery Thomas


Background: Nystagmus can be a manifestation of ocular or systemic disorders. However, it may represent a separate disease entity by itself as in idiopathic infantile nystagmus (IIN). In 2004, Kerrison et al. localised the gene causing X-linked IIN to Xq26-27 (NYS1); however, the gene/genes causing IIN had not been identified.\ud Aims and Objectives: The aims of this study were threefold.\ud 1. To ascertain families and singletons (sporadic subjects) with IIN.\ud 2. To further refine the locus NYS1 and to identify the gene causing X-linked IIN\ud 3. To describe and compare the phenotype of subjects with IIN\ud Methods: 39 families and 78 singletons with nystagmus were recruited and phenotyped.\ud Genotyping with microsatellite markers were performed in the X-linked families to refine the genetic interval at Xq26-27. Gene sequencing was carried out by our collaborators (not by the author) at the Sanger Institute. The clinical features and eye movement recordings of 90 subjects with mutations in the FRMD7 gene were compared to 48 subjects with IIN not associated with mutations in this gene (non-FRMD7 group).\ud Results:\ud I: 149 familial subjects and 78 sporadic subjects with IIN were phenotyped. 121 subjects from 30 families were diagnosed to have X-linked IIN while 28 subjects from 9 families had other diagnosis such as albinism and aniridia.\ud II: Genetic mapping in 16 families with X-linked IIN, refined the critical interval at Locus NYS1 (Xq26-17) to a 9mB region between markers DXS8072 and DXS8094 which contained about 80 genes. High throughput DNA sequencing was carried out at the Sanger Institute which led to the discovery of FRMD7, mutations in which is associated with X-linked IIN.\ud III: The median visual acuity in subjects with a FRMD7 mutation was log MAR 0.301. The number of subjects with good stereopsis (Lang positive) was higher in the FRMD7 group (93.4%) compared to subjects in the non- FRMD7 group (78.4%). None of the subjects in the FRMD7 group had severe (>15˚) anomalous head posture (AHP) while 27% of subjects in the non-FRMD7 group had AHP more than 15˚.\ud 52.17% of obligate female carriers of a FRMD7 mutation were clinically affected.\ud Discussion: This study identified the first gene causing idiopathic infantile nystagmus. The phenotypic characteristics of these subjects will help in clinically identifying subjects with IIN due to mutations in FRMD7. In addition it has generated a stage for further research into the mechanisms behind ocular motor control

Publisher: University of Leicester
Year: 2010
OAI identifier:

Suggested articles


  1. (1964). [a New Eye Syndrome with X-Chromosomal Transmission. A Family Clan with Fundus Albinism, Fovea Hypoplasia, Nystagmus, Myopia, Astigmatism and Dyschromatopsia.]. Klin Monatsbl Augenheilkd
  2. [an Unusual Congenital and Familial Congenital Malformative Combination Involving the Eye and Kidney.].
  3. (1998). [Spasmus nutans: apropos of 16 cases].
  4. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
  5. A characteristic phenotypic retinal appearance in Norrie disease.
  6. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
  7. A corrected Haldane's map function to calculate genetic distances from recombination data.
  8. A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation.
  9. A family with Axenfeld-Rieger syndrome and Peters Anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene.
  10. (1996). A gene for autosomal dominant congenital nystagmus localizes to 6p12. Genomics
  11. (1999). A gene for X-linked idiopathic congenital nystagmus (NYS1) maps to chromosome Xp11.4-p11.3.
  12. A high-resolution recombination map of the human genome.
  13. (1989). A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene.
  14. (1999). A mutation in the RIEG1 gene associated with Peters' anomaly.
  15. A neurobiological approach to acquired nystagmus.
  16. A novel frameshift mutation in FRMD7 causing X-linked idiopathic congenital nystagmus.
  17. A novel mutation in FRMD7 causing X-linked idiopathic congenital nystagmus in a large family.
  18. A rare type of hereditary nystagmus with autosomal-dominant inheritance and special phenomenon: vertical nystagmus component and disorder of the vertical and horizontal optokinetic nystagmus.
  19. A review.
  20. (1997). A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.
  21. Abnormal sperm and photoreceptor axonemes in Usher's syndrome.
  22. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
  23. Acquired nystagmus in early childhood: a presenting sign of intracranial tumor.
  24. Allegro, a new computer program for multipoint linkage analysis.
  25. (1997). Allele-sharing models: LOD scores and accurate linkage tests.
  26. Allelic variation of the FRMD7 gene in congenital idiopathic nystagmus.
  27. Analysis of the developmental SIX6 homeobox gene in patients with anophthalmia/microphthalmia.
  28. (1998). Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet
  29. Baclofen for patients with congenital periodic alternating nystagmus.
  30. (1992). Behr's syndrome and 3-methylglutaconic aciduria.
  31. (1989). Bilateral macular colobomas in Leber's congenital amaurosis. Doc Ophthalmol
  32. Candidate Gene Analysis
  33. (1994). Carrier detection in X linked ocular albinism using linked DNA polymorphisms.
  34. Cataracts and glaucoma in patients with oculocerebrorenal syndrome.
  35. Cerebellar contribution to saccades and gaze holding: a modeling approach.
  36. Cerebrooculo-hepato-renal syndrome (Arima' syndrome): a distinct clinicopathological entity.
  37. Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion.
  38. (2001). Clinical and genetic analysis of a family with X-linked congenital nystagmus (NYS1). Ophthalmic Genet
  39. (1991). Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function.
  40. Clinical and ocular motor analysis of the infantile nystagmus syndrome in the first 6 months of life.
  41. (1998). Clinical features of autosomal dominant congenital nystagmus linked to chromosome 6p12.
  42. Clinical findings in Pelizaeus-Merzbacher disease.
  43. Clinical outcomes in patients with Chiari I malformation: a review of 27 cases. Surg Neurol 2003;60:142-147; discussion
  44. (1995). Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome.
  45. Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location.
  46. (2001). Committee for the Classification of Eye Movement Abnormalities and Strabismus. A classification of eye movement abnormalities and strabismus
  47. Cone-rod dystrophy and acquired dissociated vertical nystagmus.
  48. Confirmation and refinement of a genetic locus of congenital motor nystagmus in Xq26.3-q27.1 in a Chinese family.
  49. Congenital idiopathic nystagmus in identical twins.
  50. Congenital Idiopathic Nystagmus. Incidence and occupational prognosis.
  51. (1999). Congenital motor nystagmus linked to Xq26-q27.
  52. (1993). Congenital nystagmus cosegregating with a balanced 7;15 translocation.
  53. Congenital nystagmus waveforms and foveation strategy.
  54. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin.
  55. (1992). Congenital nystagmus: rebound phenomenon following removal of contact lenses.
  56. Congenital nystagmus.
  57. Detecting polymorphisms and mutations in candidate genes.
  58. (1998). Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet
  59. Dominant macular colobomata.
  60. Downbeat nystagmus as a result of lamotrigine toxicity.
  61. Downbeat nystagmus as the salient manifestation of the Arnold-Chiari malformation.
  62. (1997). Drug therapy for acquired pendular nystagmus in multiple sclerosis.
  63. Easy calculations of lod scores and genetic risks on small computers.
  64. Effect of gene therapy on visual function in Leber's congenital amaurosis.
  65. (1999). Efficient approach to unique singlenucleotide polymorphism discovery.
  66. Epidemiology of strabismus.
  67. (1998). Exclusion of chromosome regions 6p12 and 15q11, but not chromosome region 7p11, in a German family with autosomal dominant congenital nystagmus.
  68. Expanding the phenotypic spectrum of the Baller-Gerold syndrome.
  69. (1994). Eye and head movements in patients with achromatopsia. Graefes Arch Clin Exp Ophthalmol
  70. (1996). Eye movements.
  71. Facial and physical features of Aicardi syndrome: infants to teenagers.
  72. Factors influencing the experience of oscillopsia in infantile nystagmus syndrome.
  73. Familial agenesis of the cerebellar vermis. A syndrome of episodic hyperpnea, abnormal eye movements, ataxia, and retardation.
  74. (1993). Familial remitting chorea, nystagmus, and cataracts.
  75. (1993). Familial schizencephaly.
  76. Familial vestibulocerebellar disorder maps to chromosome 13q31-q33: a new nystagmus locus.
  77. FARP2 triggers signals for Sema3Amediated axonal repulsion.
  78. Features of a syndrome with congenital cataract and hypertrophic cardiomyopathy.
  79. (2007). FRMD7 mutations in Chinese families with X-linked congenital motor nystagmus.
  80. Full-field electroretinography and marked variability in clinical phenotype of Alstrom syndrome.
  81. Generalized gangliosidosis.
  82. Genetic basis of total colourblindness among the Pingelapese islanders.
  83. (1993). Genetic heterogeneity among blue-cone monochromats.
  84. Genetic Studies on Drosophila Simulans.
  85. Genetics and Ophthalmology:
  86. (1996). Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly.
  87. (1990). GM2-gangliosidosis. Clinical and biochemical aspects of four cases.
  88. (1993). Hallermann-Streiff syndrome.
  89. Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. A clinico-pathological case study.
  90. (1996). Head and eye movements in children with low vision. Graefes Arch Clin Exp Ophthalmol
  91. (1992). Head nodding is compensatory in spasmus nutans.
  92. Hereditary Nystagmus.
  93. Hereditary studies of congenital nystagmus in a Swedish population.
  94. Heterozygous deletion of the linked genes ZIC1 and ZIC4 is involved in Dandy-Walker malformation.
  95. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.
  96. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities.
  97. (2003). Human molecular genetics. 3rd
  98. Hypervariable 'minisatellite' regions in human DNA.
  99. (1986). Ibuprofen overdose: 126 cases. Ann Emerg Med
  100. Infantile mitochondrial leucodystrophy - a case report.
  101. (1997). Infantile nystagmus. Development documented by eye movement recordings.
  102. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex.
  103. ISCEV standard for clinical pattern electroretinography--2007 update.
  104. Jeune syndrome.
  105. (1998). Karsch-Neugebauer syndrome in two sibs with unaffected parents.
  106. Karsch-Neugebauer syndrome: split foot/split hand and congenital nystagmus.
  107. (1998). Klippel-Trenaunay syndrome.
  108. (1992). Late infantile form metachromatic leukodystrophy: report of one case.
  109. Latent and congenital nystagmus in Down syndrome.
  110. latent and manifest latent nystagmus--similarities, differences and relation to strabismus.
  111. (1984). Leigh's subacute necrotizing encephalomyelopathy manifesting as spasmus nutans. Arch Ophthalmol
  112. Lithium-induced periodic alternating nystagmus.
  113. Male transmission of Apert syndrome.
  114. manifest latent, and congenital nystagmus.
  115. Manifesting heterozygosity in Norrie's disease?
  116. Manning MD. Association of Wilms's Tumor with Aniridia, Hemihypertrophy and Other Congenital Malformations.
  117. Meiotic recombination hot spots and human DNA diversity.
  118. Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.
  119. (1999). Missense mutations in the most ancient residues of the PAX6 paired domain underlie a spectrum of human congenital eye malformations. Hum Mol Genet
  120. Molecular and phenotypic characteristics of metachromatic leukodystrophy patients from Poland.
  121. (1997). Molecular cloning and characterization of CDEP, a novel human protein containing the ezrin-like domain of the band 4.1 superfamily and the Dbl homology domain of Rho guanine nucleotide exchange factors.
  122. (1989). Molecular genetics of human blue cone monochromacy.
  123. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder.
  124. (1994). Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly.
  125. Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation.
  126. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome.
  127. Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness.
  128. Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus.
  129. Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness.
  130. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.
  131. Mutations in the cone photoreceptor Gprotein alpha-subunit gene GNAT2 in patients with achromatopsia.
  132. (1998). Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.
  133. (1997). Mutations in TWIST, a basic helix-loophelix transcription factor, in Saethre-Chotzen syndrome.
  134. Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations.
  135. (1996). Natural history of Alstrom syndrome in early childhood: onset with dilated cardiomyopathy.
  136. (1986). Neonatal adrenoleukodystrophy.
  137. (1999). Neuro-ophthalmological signs during rapid intravenous administration of phenytoin.
  138. (1978). Neurological abnormalities in patients treated for hypothyroidism from early life. Arch Dis Child
  139. New approach for isolation of VNTR markers.
  140. Nineteen additional unpredicted transcripts from human chromosome 21.
  141. Norrie's disease--differential diagnosis and treatment.
  142. Nouvelle operation de nystagmus.
  143. (2007). Novel mutations of the FRMD7 gene in X-linked congenital motor nystagmus.
  144. Nystagmus characteristics in congenital stationary night blindness (CSNB).
  145. Nystagmus mimicking spasmus nutans as the presenting sign of Bardet-Biedl syndrome.
  146. Nystagmus secondary to drug exposure in utero.
  147. Ocular and pathological manifestations.
  148. (1996). Ocular findings in 55 patients with Down's syndrome.
  149. (1996). Ocular findings in Down's syndrome.
  150. Ocular findings in Turner syndrome. A prospective study.
  151. Ocular involvement in the fetal alcohol syndrome.
  152. Ocular manifestations in fetal alcohol syndrome.
  153. Ocular manifestations of Noonan syndrome.
  154. (1994). Ocular manifestations of Sotos syndrome.
  155. Ocular phenotype correlations in patients with TWIST versus FGFR3 genetic mutations.
  156. (1991). Ophthalmic findings in maple syrup urine disease. Metab Pediatr Syst Ophthalmol
  157. (1984). Ophthalmic manifestations of infantile phytanic acid storage disease. Arch Ophthalmol
  158. Ophthalmic sequelae of Crouzon syndrome.
  159. (1996). Paediatric ophthalmology. 2nd
  160. (1996). Parametric and nonparametric linkage analysis: a unified multipoint approach.
  161. Partial sight and blindness in children of the 1970 birth cohort at 10 years of age.
  162. PAX6 missense mutation in isolated foveal hypoplasia.
  163. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data.
  164. Phenotypic heterogeneity of CYP1B1: mutations in a patient with Peters' anomaly.
  165. Polysome immunoprecipitation of phenylalanine hydroxylase mRNA from rat liver and cloning of its cDNA.
  166. (1995). Pregnancy outcome after gestational exposure to amiodarone in Canada.
  167. Prevalence and inheritance of congenital nystagmus in a Swedish population.
  168. Primidone/phenobarbital-induced periodic alternating nystagmus.
  169. Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene.
  170. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders.
  171. Refinement of the localization of the X-linked ocular albinism gene.
  172. Retinal dystrophy in Jeune's syndrome.
  173. retinal image stabilization and congenital nystagmus.
  174. Reversed optokinetic nystagmus (OKN): mechanism and clinical significance.
  175. Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene.
  176. (1994). Risk factors for esotropia and exotropia.
  177. Safety and efficacy of gene transfer for Leber's congenital amaurosis.
  178. Senior-Loken syndrome (familial renal-retinal dystrophy) and Coats' disease.
  179. Senior-Loken syndrome. Case reports of two siblings and association with sensorineural deafness.
  180. Septo-optic dysplasia (de Morsier syndrome).
  181. Sequential tests for the detection of linkage.
  182. (1910). Sex Limited Inheritance in Drosophila. Science
  183. Sex-linked ocular albinism displaying typical fundus changes in the female heterozygote.
  184. Sialidosis: the cherry-red spot--myoclonus syndrome.
  185. Sickle-cell anaemia and sickle-cell trait as home- and heterozygous gene-combinations.
  186. (1990). Signs distinguishing spasmus nutans (with and without central nervous system lesions) from infantile nystagmus.
  187. Skewed X inactivation in an X linked nystagmus family resulted from a novel, p.R229G, missense mutation in the FRMD7 gene.
  188. Sorsby syndrome: a report on further generations of the original family.
  189. (1998). SOX10 mutations in patients with Waardenburg-Hirschsprung disease.
  190. (1995). Spasmus nutans. A long-term follow-up.
  191. Spasmus nutans. A quantitative prospective study.
  192. Spectrum of foveal development in albinism detected with optical coherence tomography.
  193. (2004). Standard for clinical electroretinography
  194. Survey of management of acquired nystagmus in the United Kingdom.
  195. Symposium: nystagmus. Congenital nystagmus surgery.
  196. Syndrome of epiphyseal dysplasia, short stature, microcephaly and nystagmus.
  197. Syndrome of short stature, microcephaly, mental retardation, and multiple epiphyseal dysplasia--Lowry-Wood syndrome.
  198. The Dandy-Walker syndrome. A clinicopathological study based on 28 cases.
  199. The effects of congenital nystagmus surgery.
  200. The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study.
  201. The gene disrupted in MarinescoSjogren syndrome encodes SIL1, an HSPA5 cochaperone.
  202. (1997). The homozygous complete hydatidiform mole: a unique resource for genome studies.
  203. The human PAX6 gene is mutated in two patients with aniridia.
  204. (1990). The Nance-Horan syndrome.
  205. (1991). The nature of head postures in congenital nystagmus.
  206. The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome.
  207. The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development. Hum Mol Genet 19:342-
  208. (2009). The prevalence of nystagmus: The Leicestershire nystagmus survey. Invest Ophthalmol Vis Sci
  209. The prevalence of strabismus in congenital nystagmus: the influence of anterior visual pathway disease.
  210. The retinal ciliopathies.
  211. The use of contact lenses to treat visually symptomatic congenital nystagmus.
  212. (2006). These authors contributed equally to this work Mutations in FRMD7, a newly identified member of the FERM family, cause Xlinked idiopathic congenital nystagmus. Nature Genetics.
  213. Three pedigrees of eye defects: primary hereditary nystagmus. Case study with genealogy.
  214. (1998). Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel.
  215. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
  216. (1997). Treatment of mitochondrial encephalomyopathy with a combination of cytochrome C and vitamins B1 and B2. Brain Dev
  217. Unilateral pursuit-induced congenital nystagmus.
  218. Using risk calculation to implement an extended relative pair analysis.
  219. Variable number of tandem repeat (VNTR) markers for human gene mapping.
  220. (2004). Visual evoked potentials standard
  221. Visual loss as the presenting sign of Jeune syndrome.
  222. Visual screening of Swedish children: an ophthalmological evaluation.
  223. WAGR syndrome: a clinical review of 54 cases.
  224. Waveform characteristics of manifest latent nystagmus.
  225. (2007). X-linked idiopathic infantile nystagmus associated with a missense mutation in FRMD7.
  226. X-linked infantile periodic alternating nystagmus.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.